Lijie Zhao

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer”.

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00900

N/A

0DataRank · unranked

142 citations

Lijie Zhao, Xin Han, Chong Qin, Bukeyan Miao, Donna McEachern +10 more

Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00882

N/A

0DataRank · unranked

139 citations

Lijie Zhao, Weiguo Xiang, Chong Qin, Bukeyan Miao, Donna McEachern +8 more

Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00405

N/A

0DataRank · unranked

58 citations

Lijie Zhao, Weiguo Xiang, Bukeyan Miao, Chong Qin, Mi Wang +16 more

Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2407910121

N/A

0DataRank · unranked

7 citations

Jiangbo Wei, Hao Fan, Wenlong Li, Lijie Zhao, Emma Wilkinson +10 more